000 01246 a2200289 4500
005 20250513055125.0
264 0 _c19940805
008 199408s 0 0 eng d
022 _a0267-4874
024 7 _a10.1007/BF01986523
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aElstein, M
245 0 0 _aLow dose contraceptive formulations: is further reduction in steroid dosage justified?
_h[electronic resource]
260 _bAdvances in contraception : the official journal of the Society for the Advancement of Contraception
_cMar 1994
300 _a1-4 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aContraceptives, Oral, Hormonal
_xadministration & dosage
650 0 4 _aEndometrial Neoplasms
_xprevention & control
650 0 4 _aEthinyl Estradiol
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aOvarian Neoplasms
_xprevention & control
650 0 4 _aProgestins
_xadministration & dosage
650 0 4 _aThrombosis
_xprevention & control
773 0 _tAdvances in contraception : the official journal of the Society for the Advancement of Contraception
_gvol. 10
_gno. 1
_gp. 1-4
856 4 0 _uhttps://doi.org/10.1007/BF01986523
_zAvailable from publisher's website
999 _c8029773
_d8029773